申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
公开号:US20030216383A1
公开(公告)日:2003-11-20
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formula (Ia) and (Ib) where R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, Het and X are defined herein. The compounds are useful for treating autoimmune and other diseases. Also disclosed are processes for making such novel compounds.
1
本发明揭示了一种新的cathepsin S、K、F、L和B可逆抑制化合物,其化学式为(Ia)和(Ib),其中R2、R3、R4、R5、R6、R7、R8、Het和X的定义如下。这些化合物对于治疗自身免疫和其他疾病非常有用。本发明还揭示了制备这种新化合物的方法。